SCHEMBL6401313

SCHEMBL6401313

NN1C(=O)N[C@H](c2ccccc2)C1=O

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.56
ADORA3 P0DMS8 1/20 0.56
AR P10275 1/20 0.43
KMT2A Q03164 3/20 0.41
MAPT P10636 3/20 0.41
ALDH1A1 P00352 3/20 0.41
KDM4E B2RXH2 1/20 0.41
GAA P10253 1/20 0.41
HPGD P15428 1/20 0.41
GFER P55789 1/20 0.41
HSD17B10 Q99714 1/20 0.41
MEN1 O00255 1/20 0.40
TSHR P16473 1/20 0.38
TP53 P04637 1/20 0.38
CYP1A2 P05177 1/20 0.38
CYP3A4 P08684 1/20 0.38
MAPK1 P28482 1/20 0.38
HTR2B P41595 1/20 0.38
USP2 O75604 1/20 0.37
MAPK10 P53779 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6399678 1.00 LMNA (0.56) LMNAADORA3ARKMT2AMAPT
SCHEMBL6105903 1.00 LMNA (0.56) LMNAADORA3ARKMT2AMAPT
SCHEMBL6400557 0.81 ALDH1A1 (0.41) LMNAADORA3KMT2AMAPTALDH1A1
SCHEMBL6404444 0.81 TDP1 (0.49) LMNAADORA3ARKMT2AALDH1A1
SCHEMBL6401149 0.77 KDM4E (0.48) LMNAKMT2AMAPTALDH1A1KDM4E
SCHEMBL6404736 0.77 KDM4E (0.48) LMNAKMT2AMAPTALDH1A1KDM4E
SCHEMBL77736 0.76 LMNA (0.61) LMNAADORA3ARKMT2AMAPT
SCHEMBL845936 0.76 AR (0.61) LMNAADORA3ARKMT2AALDH1A1
SCHEMBL6401309 0.74 LMNA (0.50) LMNAADORA3ARKMT2AALDH1A1
SCHEMBL6403766 0.74 GAA (0.44) KMT2AALDH1A1KDM4EGAAMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050054696-A1 Indole compounds and medicinal use thereof JAPAN TOBACCO INC. (JP) 2005-03-10 US claimed
EP-1452526-A1 INDOLE COMPOUND AND MEDICINAL USE THEREOF JAPAN TOBACCO INC. (JP) 2004-09-01 EP claimed
US-20050054696-A1 Indole compounds and medicinal use thereof JAPAN TOBACCO INC. (JP) 2005-03-10 US disclosed
EP-1452526-A1 INDOLE COMPOUND AND MEDICINAL USE THEREOF JAPAN TOBACCO INC. (JP) 2004-09-01 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050054696-A1 Indole compounds and medicinal use thereof IDO1, GPR119, SLC5A1 LMNA 2465/4885ADORA3 839/4885AR 2364/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.